Clinical Trial Update: Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a CBD/CBD-A oral extract for resting-state EEG changes and neuropathic pain symptoms in spinal cord injury. The study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Spinal Cord Injury

Drugs mentioned

• CBD/CBD-A oral extract (cannabidiol and cannabidiolic acid)

Snippet

Sponsor: University of Miami | Conditions: SCI - Spinal Cord Injury, Neuropathic Pain | Phase 1, Phase 2 | Status: RECRUITING